Today, the US Food and Drug Administration has granted the Moderna COVID vaccine its full approval for use in persons aged 18 and older. It has been in use under emergency authorization since December 18, 2020. The vaccine has been named Spikevax going forward.
Press release: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-key-action-approving-second-covid-19-vaccine